How does subintimal angioplasty compare to transluminal angioplasty for the treatment of femoral occlusive disease?

• Published in: International journal of surgery (London, England) Vol. 12; no. 4; pp. 361 - 364
• Main Authors: Klimach, S.G., Gollop, N.D., Ellis, J., Cathcart, P.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.01.2014
• Subjects: Angioplasty - methods; Arterial Occlusive Diseases - surgery; Cohort Studies; Femoral Artery - surgery; Femoral occlusive disease; Humans; Subintimal angioplasty; Surgery; Transluminal angioplasty; Treatment Outcome; Transluminal angioplasty; Subintimal angioplasty; DVT; ABPI; Femoral occlusive disease; ROS; SIA; TASC; TA; SR; retrospective observational study; Transatlantic Inter-Society Consensus; systematic review; deep vein thrombosis; ankle brachial pressure index
• ISSN: 1743-9191; 1743-9159; 1743-9159
• DOI: 10.1016/j.ijsu.2014.01.007

A best evidence topic in surgery was written according to a structured protocol. The question addressed how subintimal angioplasty (SIA) compares to transluminal angioplasty (TA) for the treatment of femoral occlusive disease. One hundred and thirty two papers were found using the reported search; the 5 which represented the best evidence to answer the question are discussed. The evidence on this subject is limited; there are no randomised controlled trials (RCTs) comparing SIA to TA for pathologically equivalent lesions. However SIA remains a safe and effective alternative to surgical bypass grafting when TA cannot be performed.